The new myth

PharmacoEconomics

Volumn 26, Issue 1, 2008, Pages 1-4

  Brouwer, Werner ^a   Van Exel, Job ^a   Baker, Rachel ^b   Donaldson, Cam ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Decision making; Quality adjusted life years

Indexed keywords

ECONOMIC EVALUATION; EDITORIAL; HEALTH ECONOMICS; LITERATURE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SOCIAL PSYCHOLOGY; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE PLANNING; HUMAN; RESOURCE ALLOCATION; SOCIOECONOMICS; UNCERTAINTY;

COST-BENEFIT ANALYSIS; HEALTH PLANNING; HUMANS; QUALITY-ADJUSTED LIFE YEARS; RESOURCE ALLOCATION; SOCIAL VALUES; UNCERTAINTY; VALUE OF LIFE;

EID: 41949122603     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200826010-00001     Document Type: Editorial

References (15)

1. Gafni A, Birch S. Incremental cost effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med 2006; 62: 2091-100
2. 6th iHEA World Congress; 2007 Jul 8-11; Copenhagen
3. Boadway R, Bruce N. Welfare economics. Oxford: Basil Backwell, 1984
4. Gravelle H, Brouwer WBF, Niessen LW, et al. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ 2007; 16 (3): 307-17
5. Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000; 20 (3): 332-42
6. Taylor RS, Drummond MF, Salkeld G, et al. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 2004 Oct 23; 329 (7472): 972-5
7. Dranove D. What's your life worth? New York: FT Prentice Hall, 2003
8. Williams A. What could be nicer than NICE? OHE Annual Lecture 2004. London: Office of Health Economics, 2004
9. Williams A. Intergenerational equity: an exploration of the fair innings argument. Health Econ 1997; 6 (2): 117-32
10. Stolk EA, van Donselaar G, Brouwer WBF, et al. Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics 2004; 22 (17): 1097-107
11. Hammond PJ. Interpersonal comparisons of utility: why and how they are and should be made. In: Elster J, Roemer JE, editors. Interpersonal comparisons of well-being. Cambridge (MA): Cambridge University Press, 1991
12. Smith R, Richardson J. Can we estimate the 'social' value of a QALY? Four core issues to resolve. Health Policy 2005; 74 (1): 77-84
13. Bleichrodt H, Quiggin J. Life cycle preferences over consumption and health: when is cost effectiveness analysis equivalent to cost benefit analysis? J Health Econ 1999; 18: 681-708
14. Williams A, Cookson R. Equity in health. In: Culyer AJ, New-house JP, editors. Handbook of health economics. Amsterdam: Elsevier Science, 2000
15. European Value of a Quality Adjusted Life Year [online]. Available from URL: http://research.ncl.ac.uk/eurovaq [Accessed 2007 Dec 06]